Cross posted from Nature’s The Great Beyond blog.
A safety trial of a stem cell therapy for stroke has enrolled its first patient, the UK company developing the treatment announced today.
Surrey-based ReNeuron’s treatment will transplant neural stem cells into the brains of stroke patients, in hopes of promoting the renewal of damaged areas. The firm won approval for the trial of 12 patients last year, after establishing that the therapy is safe and effective in rat models of stroke.